S&P 500 Technology Sector SEC Filings — May 26, 2026

Announced $225M cash sale of 10 data centers to I Squared Capital, a strategic divestiture of non-core assets that could streamline operations and improve ROIC; transaction expected to close on or after June 12, 2026, subject to HSR clearance; no gain/loss disclosed but cash infusion strengthens balance sheet

Revenue declined 5.1% YoY to $594M in 2024 from $626M in 2023, with all three segments (Provider flat, Payer -6.9%, Life Sciences -12.3%) underperforming; net income swung to a loss of $292M from a profit of $49M, driven by a $108M goodwill impairment and elevated SG&A; preliminary 2025 guidance of $584M-$589M implies further 1-2% decline

Adjusted EBITDA fell 28.5% to $94M in 2024 from $132M in 2023, indicating significant operational deleveraging; effective tax rate surged to 32.3% from 17.8% YoY, adding to cash flow pressure; equity in net loss of unconsolidated subsidiaries increased to $7.2M from $0.3M

Diana Shipping's unsolicited $23.50/share tender offer is being vigorously opposed by Genco, which argues the price is inadequate and discounts NAV; Genco's fleet grew 20% in 2025 without issuing new shares, demonstrating organic value creation; however, stock has closed above offer only 40% of trading days in 2026, suggesting market skepticism

Diana's own market cap is $321M, just 45% of its stated NAV of $710M, and its lagging time charter fixtures have cost Diana shareholders over $40M in 2026 alone, weakening Diana's credibility as a bidder and potentially increasing Genco's bargaining power [BULLISH for Genco]

Director John F. McKenzie received 2,003,337 withheld votes (~22.6% of votes cast), a notable level of shareholder dissent that may signal governance concerns or dissatisfaction with performance; 2026 Equity Incentive Plan passed with strong support (8.2M for vs 0.6M against) [NEUTRAL with governance risk]

All 11 director nominees received over 9.4M votes 'For', and auditor ratification passed with 11.4M votes (99.9% approval), indicating strong shareholder alignment and low governance risk; broker non-votes were significant on compensation proposal (2.1M), but overall sentiment is positive

All 5 director nominees elected with overwhelming support (>593,000 votes each), and auditor ratification passed with 611,467 votes (99.97% approval), reflecting stable governance and no material concerns

Revenue declined 5.1% YoY in 2024, net income swung to a loss of $292M from a profit of $49M, and adjusted EBITDA fell 28.5% to $94M; preliminary 2025 guidance of $584M-$589M implies further decline of 1-2%, signaling a prolonged turnaround

A $108.2M goodwill impairment in 2024, combined with a $7.2M equity loss from unconsolidated subsidiaries and a $20.3M non-operating expense (vs $25.5M income in 2023), suggests significant asset quality and investment issues

Life Sciences segment revenue declined 12.3% YoY to $54.0M, Payer segment fell 6.9% to $67.3M, and Provider was flat at $472.6M; all three segments experienced gross profit declines, indicating broad-based competitive or demand pressure

Diana Shipping's unsolicited tender offer creates a binary event; Genco's stock has closed above the $23.50 offer only 40% of trading days in 2026, and dry bulk peers trade at a ~25% discount to NAV, implying downside risk if the deal fails and no superior offer emerges

Genco acknowledges that dry bulk peers trade at a ~25% discount to NAV, and its own stock has underperformed the offer price 60% of the time in 2026, suggesting that without a transaction, shares could revert to a discount, eroding shareholder value

Director John F. McKenzie received 22.6% withheld votes, a significant protest vote that may indicate governance issues or performance dissatisfaction; while not a controlling risk, it warrants monitoring for escalation

The $225M data center sale lacks disclosed financial impact (gain/loss, tax implications), and the HSR waiting period creates execution risk; if the deal falls through, Cogent remains with non-core assets that may continue to drag on margins

The $225M sale of 10 data centers to I Squared Capital allows Cogent to focus on its all-optical IP network, which serves 306 markets globally; this divestiture could improve ROIC and margins, and the cash infusion may fund network expansion or shareholder returns; closing expected on/after June 12, 2026

Despite severe financial deterioration, the filing of long-delayed 2023 and 2024 10-Ks is a major milestone toward SEC compliance; the hiring of Strategic Financial Advisor Leland Westerfield (effective June 1, 2026 through March 31, 2027) to assist with CFO transition and remediation of material weaknesses signals a credible turnaround effort; if successful, the stock could re-rate

With Diana Shipping offering $23.50/share and Genco arguing it's inadequate, there may be an arbitrage opportunity if a higher bid emerges or if Genco's defense succeeds in extracting a better price; Genco's fleet growth of 20% in 2025 without equity dilution is a positive signal; the tender offer timeline creates a catalyst

With strong shareholder support (99.9% auditor approval, all directors elected with >9.4M votes) and a positive sentiment, this bank offers a low-volatility, high-governance-quality exposure for investors seeking defensive positioning in the financial sector

The overwhelming support for directors and auditor (99.97% approval) indicates a well-governed company with no shareholder dissent; this could be a safe harbor for investors prioritizing governance quality

Genco's argument that Diana's offer lacks a control premium and that Diana's own market cap is only 45% of its NAV, combined with Diana's $40M in losses from lagging charters, weakens the bidder's position; this could lead to a higher offer or a white knight, creating upside for Genco shareholders

Cogent's $225M data center sale to I Squared Capital exemplifies a trend where technology companies shed non-core assets to streamline operations and improve capital efficiency; this mirrors broader sector moves toward asset-light models and could signal similar actions from peers

Veradigm's delayed filings, goodwill impairment, and revenue declines highlight ongoing challenges in the healthcare IT subsector, where legacy players face competitive pressure from cloud-native solutions; the 5.1% revenue decline and 28.5% EBITDA drop suggest sector-wide headwinds

The Genco-Diana proxy fight underscores increased activist and M&A activity in the shipping sector, where NAV discounts and fragmented ownership create arbitrage opportunities; this could spill over into other asset-heavy technology-adjacent sectors

NorthEast Community Bancorp, First Northern Community Bancorp, and Portsmouth Square all show strong shareholder support for routine governance items, with auditor approvals exceeding 99% in most cases; this suggests a low-risk governance environment in smaller financial institutions, though NorthEast's 22.6% withheld votes for one director is an outlier

Cogent's $225M cash sale and Veradigm's consulting agreement (with $45,937.50/month fees and a $100,000 RSU award) highlight a focus on liquidity and financial remediation; this trend may indicate that companies are prioritizing cash preservation and debt reduction amid uncertain macroeconomic conditions

Monitor for HSR Act clearance and closing on/after June 12, 2026; any delay or termination could signal regulatory or counterparty issues; also watch for disclosure of gain/loss on sale

Preliminary 2025 revenue guidance of $584M-$589M implies further decline; watch for Q1 2025 earnings (if filed) and any updates to guidance; the consulting agreement with Leland Westerfield (June 1, 2026 start) is a key catalyst for financial remediation

The tender offer is ongoing; watch for any revised bids, shareholder votes, or regulatory developments; Genco's stock trading relative to the $23.50 offer price will signal market expectations

Monitor for any shareholder activism or board changes following the 22.6% withheld votes for Director McKenzie; the next earnings call or proxy statement may provide context

The non-binding advisory compensation proposal had 2.1M broker non-votes; watch for any say-on-pay concerns in future filings or shareholder communications

No insider activity was reported in these filings, but the consulting agreement with Westerfield includes a $100,000 RSU award contingent on filing 2023/2024 reports; any insider buying or selling post-filing would be a strong signal

With the annual meeting held on May 20, 2026, for fiscal year ending June 30, 2026, watch for year-end earnings and any material changes in operations or capital allocation